Purchase Order 36C24126P0199
- Not listed
- On November 1, 2019, the Veterans Integrated Service Network 1 (VISN 1), a regional network within the Department of Veterans Affairs, awarded a purchase order valued at $470,781 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the procurement of radiopharmaceuticals. The contract, structured as a firm fixed-price purchase order with no set-aside designation, is scheduled for completion by December 31, 2025, and covers the supply and delivery of...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10), awarded a $75,228.11 firm fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on December 18, 2025, for the supply of nuclear medicine radiopharmaceuticals. The contract, which carries an ultimate completion date of December 17, 2028, represents a delivery order under a larger indefinite delivery vehicle established between the VA and Jubilant...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a delivery order valued at $521,738.46 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on March 5, 2026, with an ultimate completion date of March 4, 2027. This firm fixed-price delivery order, with no set-aside designation, procures radiopharmaceuticals for delivery to the Norcross, Georgia location. Jubilant Radiopharma, a for-profit small disadvantaged business...
- The U.S. Department of Veterans Affairs (VA) awarded a $150,000.00 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA's Veterans Integrated Service Network (VISN) 10, which covers the supply of specialized...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 20, awarded a $110,551.19 firm fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on July 1, 2024, for radiopharmaceuticals to support the Portland Veterans Affairs Medical Center. The contract, which carries no set-aside designation, is scheduled for completion by June 30, 2025, with performance occurring at the vendor's facility in Norcross,...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a $516,060.56 firm fixed-price delivery order by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs, on March 5, 2025. The contract, which is not set aside for small businesses despite the contractor's small disadvantaged business certification, calls for the supply of radiopharmaceuticals to support nuclear medicine operations at VA medical...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a delivery order valued at $382,001.07 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on March 1, 2025, for the supply of nuclear medicine imaging radio-therapeutic isotopes. The contract, which carries a firm fixed price structure with an ultimate completion date of February 28, 2026, was awarded without set-aside designation. Jubilant Radiopharma, a small...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a $71,447.90 firm fixed price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on October 1, 2023, for the supply of nuclear radiopharmaceuticals and medical imaging agents. The contract, which was not set aside, is scheduled for completion by September 30, 2024, with performance occurring in San Francisco, California. Jubilant Radiopharma, a...
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a delivery order valued at $1.49 million on January 5, 2023, for the supply of radiopharmaceuticals to the Veterans Integrated Service Network 8 (VISN 8), a regional healthcare network within the Department of Veterans Affairs. The contract, which was not set aside, carries a firm fixed-price structure with an ultimate completion date of September 30, 2023, and is to be performed in Norcross, Georgia....
- Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a delivery order valued at $104,805.52 for radiopharmaceuticals by Veterans Integrated Service Network 6 (VISN 6), with an ultimate completion date of March 4, 2026. This firm fixed-price delivery order was issued without set-aside designation on March 5, 2024, and will be performed in Norcross, Georgia. The awardee is a for-profit small disadvantaged business that manufactures and distributes...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), awarded a $94,000 firm fixed-price purchase order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for radiopharmaceuticals with a performance location in North Providence, Rhode Island. The contract was awarded on March 6, 2026, with an ultimate completion date of March 5, 2027, and does not carry a set-aside designation. Jubilant Radiopharma is a small disadvantaged business subsidiary of Jubilant Life Sciences Limited that specializes in manufacturing and distributing radiopharmaceuticals and nuclear medicine products essential to VA healthcare operations, including diagnostic imaging agents, medical isotopes, and therapeutic compounds. This purchase order represents a single delivery against Jubilant Radiopharma's extensive portfolio of Indefinite Delivery Vehicles with the Department of Veterans Affairs. The company maintains substantial contract vehicles across multiple VISNs, including a $39.8 million multiple-award indefinite delivery contract with VISN 8 and several million-dollar agreements with other regional networks. Jubilant Radiopharma's radiopharmaceutical products—such as technetium-99m, gallium-68 Dotatate, fluorine-18 fluorodeoxyglucose, and other medical isotopes—support critical nuclear medicine procedures, positron emission tomography scans, cardiac imaging, and cancer diagnostics across the VA's nationwide system of medical facilities. The company serves as a critical supplier ensuring veterans have consistent access to advanced diagnostic imaging and therapeutic nuclear medicine products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $94.0k | 3/5/26 |